Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meiji Yasuda Asset Management is a prominent Japanese investment management firm and a subsidiary of Meiji Yasuda Life Insurance Company. Headquartered in Tokyo, the firm provides a wide range of investment advisory and management services, including the management of investment trusts and discretionary investment accounts for institutional and individual clients. While the company manages portfolios that may include significant holdings in the global healthcare, pharmaceutical, and biotechnology sectors, it is primarily a financial services institution. It does not engage in independent life sciences research, drug discovery, or clinical development. The firm was formed through the merger of the asset management arms of Meiji Life and Yasuda Life following the merger of their parent companies in 2004.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yasuda Asset Management.